Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vicki A Morrison

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
The Lancet. Infectious Diseases|August 11, 2019
Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trialKathleen M Mullane, Vicki A Morrison, Luis H Camacho, et al.
JCO Oncology Practice|September 20, 2022
Oncologists' Perspectives on Individualizing Dose Selection for Patients With Metastatic CancerRachel B Jimenez, Caroline Schenkel, Laura A Levit, et al.
Open Forum Infectious Diseases|July 16, 2020
Immunogenicity of Inactivated Varicella Zoster Vaccine in Autologous Hematopoietic Stem Cell Transplant Recipients and Patients With Solid or Hematologic CancerMichael J Boeckh, Ann M Arvin, Kathleen M Mullane, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 8, 2008
Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of AmericaThomas J Walsh, Elias J Anaissie, David W Denning, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 5, 2012
Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guidelineJennifer J Griggs, Pamela B Mangu, Holly Anderson, et al.
Annals of Internal Medicine|May 5, 2010
Safety of herpes zoster vaccine in the shingles prevention study: a randomized trialMichael S Simberkoff, Robert D Arbeit, Gary R Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 3, 2021
Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline UpdateJennifer J Griggs, Kari Bohlke, Edward P Balaban, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 3, 2016
Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of AmericaThomas F Patterson, George R Thompson, David W Denning, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 2, 2016
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of AmericaThomas F Patterson, George R Thompson, David W Denning, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 23, 2014
Long-term persistence of zoster vaccine efficacyVicki A Morrison, Gary R Johnson, Kenneth E Schmader, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
The Lancet. Infectious Diseases|August 11, 2019
Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trialKathleen M Mullane, Vicki A Morrison, Luis H Camacho, et al.
JCO Oncology Practice|September 20, 2022
Oncologists' Perspectives on Individualizing Dose Selection for Patients With Metastatic CancerRachel B Jimenez, Caroline Schenkel, Laura A Levit, et al.
Open Forum Infectious Diseases|July 16, 2020
Immunogenicity of Inactivated Varicella Zoster Vaccine in Autologous Hematopoietic Stem Cell Transplant Recipients and Patients With Solid or Hematologic CancerMichael J Boeckh, Ann M Arvin, Kathleen M Mullane, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 8, 2008
Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of AmericaThomas J Walsh, Elias J Anaissie, David W Denning, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 5, 2012
Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guidelineJennifer J Griggs, Pamela B Mangu, Holly Anderson, et al.
Annals of Internal Medicine|May 5, 2010
Safety of herpes zoster vaccine in the shingles prevention study: a randomized trialMichael S Simberkoff, Robert D Arbeit, Gary R Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 3, 2021
Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline UpdateJennifer J Griggs, Kari Bohlke, Edward P Balaban, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 3, 2016
Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of AmericaThomas F Patterson, George R Thompson, David W Denning, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 2, 2016
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of AmericaThomas F Patterson, George R Thompson, David W Denning, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 23, 2014
Long-term persistence of zoster vaccine efficacyVicki A Morrison, Gary R Johnson, Kenneth E Schmader, et al.
Pageof 9